DK3596080T3 - Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater - Google Patents

Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater Download PDF

Info

Publication number: DK3596080T3
Authority: DK; Denmark
Prior art keywords: pyrimidine derivatives; pharmacological active; substituted pyrazolo; active alicyclic; alicyclic
Prior art date: 2017-03-13

Application number

DK18713016.6T

Other languages

English (en)

Inventor

István Borza

János Éles

Zsuzsa Hadady

Viktor Román

Original Assignee

Richter Gedeon Nyrt

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2017-03-13

Filing date

2018-03-12

Publication date

2021-11-15

2018-03-12 Application filed by Richter Gedeon Nyrt filed Critical Richter Gedeon Nyrt

2021-11-15 Application granted granted Critical

2021-11-15 Publication of DK3596080T3 publication Critical patent/DK3596080T3/da

Links

230000000144 pharmacologic effect Effects 0.000 title 1
LDIJKUBTLZTFRG-UHFFFAOYSA-N pyrazolo[1,5-a]pyrimidine Chemical class N1=CC=CN2N=CC=C21 LDIJKUBTLZTFRG-UHFFFAOYSA-N 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
- C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
- C07D491/14—Ortho-condensed systems
- C07D491/147—Ortho-condensed systems the condensed system containing one ring with oxygen as ring hetero atom and two rings with nitrogen as ring hetero atom

DK18713016.6T 2017-03-13 2018-03-12 Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater DK3596080T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
HU1700108A HU231058B1 (hu)	2017-03-13	2017-03-13	Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
PCT/IB2018/051599 WO2018167630A1 (en)	2017-03-13	2018-03-12	PHARMACOLOGICALLY ACTIVE ALICYCLIC-SUBSTITUTED PYRAZOLO[1,5-a]PYRIMIDINE DERIVATIVES

Publications (1)

Publication Number	Publication Date
DK3596080T3 true DK3596080T3 (da)	2021-11-15

Family

ID=89992389

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK18713016.6T DK3596080T3 (da)	2017-03-13	2018-03-12	Farmakologisk aktive alicyclisk-substitueret pyrazolo[1,5-a]pyrimidin-derivater

Country Status (32)

Country	Link
US (1)	US11026946B2 (da)
EP (1)	EP3596080B1 (da)
JP (1)	JP7153662B2 (da)
KR (1)	KR20190127779A (da)
CN (1)	CN110431142A (da)
AR (1)	AR111176A1 (da)
AU (1)	AU2018235266B2 (da)
BR (1)	BR112019018843A2 (da)
CA (1)	CA3056185A1 (da)
CL (1)	CL2019002601A1 (da)
CO (1)	CO2019010120A2 (da)
CY (1)	CY1124708T1 (da)
DK (1)	DK3596080T3 (da)
EA (1)	EA038756B1 (da)
EC (1)	ECSP19072975A (da)
ES (1)	ES2893824T3 (da)
GE (1)	GEP20217256B (da)
HR (1)	HRP20211850T1 (da)
HU (2)	HU231058B1 (da)
IL (1)	IL268923A (da)
LT (1)	LT3596080T (da)
MX (1)	MX2019011000A (da)
MY (1)	MY195262A (da)
PE (1)	PE20191646A1 (da)
PH (1)	PH12019501968A1 (da)
PL (1)	PL3596080T3 (da)
PT (1)	PT3596080T (da)
RS (1)	RS62533B1 (da)
SG (1)	SG11201907864YA (da)
SI (1)	SI3596080T1 (da)
UA (1)	UA124783C2 (da)
WO (1)	WO2018167630A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HU231057B1 (hu)	2017-03-13	2020-04-28	Richter Gedeon Nyrt	Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
TW202202495A (zh)	2020-03-26	2022-01-16	匈牙利商羅特格登公司	作為ｇａｍｍａ－胺基丁酸Ａ受體次單元ａｌｐｈａ５受體調節劑之㖠啶及吡啶并〔３，４－ｃ〕嗒𠯤衍生物
TW202220992A (zh)	2020-08-05	2022-06-01	匈牙利商羅特格登公司	具藥理活性之經雜環取代的吡唑并〔１，５－ａ〕嘧啶衍生物
HUP2100338A1 (hu)	2021-09-29	2023-04-28	Richter Gedeon Nyrt	GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2005094828A1 (en)	2004-03-02	2005-10-13	F. Hoffmann-La Roche Ag	4- (sulfanyl-pyrimidin-4-ylmethyl) -morpholine derivatives and related compounds as gaba receptor ligands for the treatment of anxiety, depression and epilepsy
GB0512844D0 (en)	2005-06-23	2005-08-03	Novartis Ag	Organic compounds
KR100753017B1 (ko) *	2006-05-25	2007-08-30	한국화학연구원	7-(3,4-디알콕시페닐)-피라졸로[1,5-ａ]피리미딘 화합물을포함하는 관절염, 아토피 피부염, 백혈병을 포함한 암 및알쯔하이머, 우울증 또는 기억력 감소 등의 뇌질환의 치료및 예방을 위한 약제학적 조성물
JP5432982B2 (ja) *	2008-03-31	2014-03-05	武田薬品工業株式会社	アポトーシスシグナル調節キナーゼ１阻害剤
TWI648281B (zh)	2013-10-17	2019-01-21	日商安斯泰來製藥股份有限公司	含硫二環式化合物
EP3286192A1 (en)	2015-04-20	2018-02-28	AbbVie Deutschland GmbH & Co KG	Substituted pyrazolopyrimidines and method of use
JP2018199623A (ja) *	2015-10-22	2018-12-20	大正製薬株式会社	含窒素縮合複素環化合物
HU231057B1 (hu)	2017-03-13	2020-04-28	Richter Gedeon Nyrt	Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok

2017
- 2017-03-13 HU HU1700108A patent/HU231058B1/hu not_active IP Right Cessation
2018
- 2018-03-12 EP EP18713016.6A patent/EP3596080B1/en active Active
- 2018-03-12 MX MX2019011000A patent/MX2019011000A/es unknown
- 2018-03-12 DK DK18713016.6T patent/DK3596080T3/da active
- 2018-03-12 GE GEAP201815192A patent/GEP20217256B/en unknown
- 2018-03-12 KR KR1020197028833A patent/KR20190127779A/ko not_active Application Discontinuation
- 2018-03-12 PL PL18713016T patent/PL3596080T3/pl unknown
- 2018-03-12 JP JP2019549366A patent/JP7153662B2/ja active Active
- 2018-03-12 LT LTEPPCT/IB2018/051599T patent/LT3596080T/lt unknown
- 2018-03-12 SG SG11201907864YA patent/SG11201907864YA/en unknown
- 2018-03-12 HR HRP20211850TT patent/HRP20211850T1/hr unknown
- 2018-03-12 RS RS20211334A patent/RS62533B1/sr unknown
- 2018-03-12 HU HUE18713016A patent/HUE056562T2/hu unknown
- 2018-03-12 US US16/493,453 patent/US11026946B2/en active Active
- 2018-03-12 WO PCT/IB2018/051599 patent/WO2018167630A1/en unknown
- 2018-03-12 MY MYPI2019004947A patent/MY195262A/en unknown
- 2018-03-12 PE PE2019001773A patent/PE20191646A1/es unknown
- 2018-03-12 ES ES18713016T patent/ES2893824T3/es active Active
- 2018-03-12 PT PT18713016T patent/PT3596080T/pt unknown
- 2018-03-12 AU AU2018235266A patent/AU2018235266B2/en not_active Ceased
- 2018-03-12 CA CA3056185A patent/CA3056185A1/en active Pending
- 2018-03-12 BR BR112019018843A patent/BR112019018843A2/pt not_active Application Discontinuation
- 2018-03-12 CN CN201880017859.XA patent/CN110431142A/zh active Pending
- 2018-03-12 SI SI201830495T patent/SI3596080T1/sl unknown
- 2018-03-12 UA UAA201910328A patent/UA124783C2/uk unknown
- 2018-03-12 EA EA201992127A patent/EA038756B1/ru unknown
- 2018-03-13 AR ARP180100580A patent/AR111176A1/es unknown
2019
- 2019-08-26 IL IL26892319A patent/IL268923A/en unknown
- 2019-08-27 PH PH12019501968A patent/PH12019501968A1/en unknown
- 2019-09-12 CL CL2019002601A patent/CL2019002601A1/es unknown
- 2019-09-18 CO CONC2019/0010120A patent/CO2019010120A2/es unknown
- 2019-10-10 EC ECSENADI201972975A patent/ECSP19072975A/es unknown
2021
- 2021-11-08 CY CY20211100964T patent/CY1124708T1/el unknown

Also Published As

Publication number	Publication date
HUP1700108A2 (en)	2018-09-28
SG11201907864YA (en)	2019-09-27
EA038756B1 (ru)	2021-10-14
CY1124708T1 (el)	2022-07-22
WO2018167630A1 (en)	2018-09-20
BR112019018843A2 (pt)	2020-04-14
CL2019002601A1 (es)	2020-01-24
AU2018235266A1 (en)	2019-10-17
HRP20211850T1 (hr)	2022-03-04
EP3596080B1 (en)	2021-09-01
ES2893824T3 (es)	2022-02-10
AU2018235266B2 (en)	2021-09-30
JP7153662B2 (ja)	2022-10-14
HU231058B1 (hu)	2020-04-28
PE20191646A1 (es)	2019-11-07
UA124783C2 (uk)	2021-11-17
PL3596080T3 (pl)	2022-01-31
CA3056185A1 (en)	2018-09-20
US11026946B2 (en)	2021-06-08
MX2019011000A (es)	2019-10-17
PT3596080T (pt)	2021-10-22
PH12019501968A1 (en)	2020-06-29
HUE056562T2 (hu)	2022-02-28
JP2020510041A (ja)	2020-04-02
SI3596080T1 (sl)	2022-01-31
MY195262A (en)	2023-01-11
GEP20217256B (en)	2021-05-25
EP3596080A1 (en)	2020-01-22
CO2019010120A2 (es)	2019-10-09
EA201992127A1 (ru)	2020-02-06
KR20190127779A (ko)	2019-11-13
CN110431142A (zh)	2019-11-08
AR111176A1 (es)	2019-06-12
LT3596080T (lt)	2021-11-25
ECSP19072975A (es)	2019-11-30
IL268923A (en)	2019-10-31
RS62533B1 (sr)	2021-11-30
US20200129515A1 (en)	2020-04-30

Publication	Publication Date	Title
DK3478682T3 (da)	2021-09-13	[1,2,4]triazolo[1,5-a]pyridinylsubstituerede indolforbindelser
HK1258157A1 (zh)	2019-11-08	作為jak抑制劑的吡唑並[1，5-a]吡嗪-4-基衍生物
HRP20190361T1 (hr)	2019-04-05	Derivati triazolo[4,5-d]pirimidina kao antagonisti cb2 receptora
EP3268000A4 (en)	2018-08-22	Pyrazolo[1,5-a][1,3,5]triazine and pyrazolo[1,5-a]pyrimidine derivatives as cdk inhibitors
IL254224A0 (en)	2017-10-31	7-substituted 5-alkyl-[4,2,1]triazolo[5,1-a]pyrimidine derivatives as pde2 inhibitors
IL268923A (en)	2019-10-31	History of alicyclic-converted pyrazolo[5,1-a]pyrimidine pharmacological activity
HUE056561T2 (hu)	2022-02-28	Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
IL262673A (en)	2018-12-31	Pyrazolo[1,5-a]pyrimidine compound
BR112016011072A8 (pt)	2018-01-30	7-benzil-4-(2-metilbenzil)-2,4,6,7,8,9-hexahidroimidazo[1,2-a]pirido[3,4-e]pirimidin-5(1h)-ona, sais destes e métodos de uso.
IL290419A (en)	2022-04-01	Imidazo[a-1,5]pyrazine derivatives as inhibitors of pi3k delta
IL272988A (en)	2020-04-30	Imidazo-[1,5-A]pyrazine derivatives as PI3K-delta inhibitors
TH1601001194A (th)	2017-10-19	อนุพันธ์ไตรอะโซโล[4,5-d]ไพริมิดีน ใหม่